Skip to main content

Market Overview

Why BioCryst, Ocugen And Voyager Therapeutics Are Moving Today

Share:
Why BioCryst, Ocugen And Voyager Therapeutics Are Moving Today

Voyager Therapeutics (NASDAQ: VYGR) shares are trading lower Wednesday after the company announced that the FDA had notified Neurocrine that it placed a clinical hold on the RESTORE-1 clinical trials of the NBIb1-817.

Voyager planned to support Neurocrine by sponsoring its trial.

Voyager Therapeutics is functional in the United States biotechnology industry. Its focus lies in the research and development of gene therapies for the cure of severe diseases of the central nervous system such as Parkinson's, Huntington's and Alzheimer's disease.

Voyager Therapeutics shares were trading down 7.63% at 7.39. The stock has a 52-week high of $14.62 and a 52-week low of $6.26.

BioCryst Pharmaceuticals (NASDAQ: BCRX) shares are trading higher after the company announced FDA approval of its supplemental new drug application for RAPIVAB, expanding patient population to include children six months and older.

BioCryst Pharmaceuticals is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, with the aim of blocking key enzymes involved in infectious and inflammatory diseases.

BioCryst Pharmaceuticals shares were trading at $10.35. The stock has a 52-week high of $12.90 and a 52-week low of $1.58.

Ocugen (NASDAQ: OCGN) shares are trading lower as a potential sell-off after the stock increased over 100% yesterday following a report of a deal for the commercialization of its Covaxin in US Markets with Bharat Biotech.

Ocugen Inc is a clinical-stage biopharmaceutical company. It is focused on discovering, developing and commercializing a pipeline of innovative therapies that address rare and underserved eye diseases.

Ocugen shares were trading down 15.92% at $2.74. The stock has a 52-week high of $3.73 and a 52-week low of 17 cents.

 

 

Related Articles (BCRX + OCGN)

View Comments and Join the Discussion!

Posted-In: why it's movingNews Penny Stocks Small Cap Movers Trading Ideas

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com